Researchers from several universities in the United Kingdom will carry out a series of tests and controls of the prototype vaccine, as part of a project of 4.4 million pounds sterling (6.6 million dollars) announced today.Scientists estimate that the first vaccines to help delay or possibly prevent type 1 diabetes, which in Britain affects about 300,000 people, will be available within the next ten years.
Dr. Alasdair Rankin, director of research at the Diabetes UK group, said that vaccines “are of enormous importance because they have the potential to transform the lives of hundreds of thousands of people living with type 1 diabetes, in addition to taking asuch sinned cure of the disease. ”People with type 1 diabetes, the most common among children, cannot produce insulin and require daily injections, in addition to being forced to maintain a healthy diet and exercise regularly.
British research, funded by Diabetes UK, by Tesco and the JDRF charity group, was announced at the annual diabetes conference at the Excel Delondres Convention Center.It will consist of four separate studies conducted by British institutions.The King’s College in London will lead the first essay of a vaccine prototype in children and adolescents living with that disease.
The University of Cardiff will seek to develop “immunotherapy” tests in hospitals in the United Kingdom, training doctors and researchers, Imperial College will recruit volunteers to participate in a vaccine test, while King’s College will establish laboratories to study the results.
“Today, type 1 diabetes is an inevitable condition that has a huge impact on the lives of more than 300,000 people in the United Kingdom.Handling diabetes is a daily challenge and too many people suffer from health complications or die early, ”said Rankin.
"These studies will help us change all that, approaching as never before prevention and finally the cure of the disease," said the expert.Rankin explained that investigations "will not be easy or obtain results from one day to another.""The first vaccines probably help people in order to the development of type 1 diabetes instead of preventing it from appearing," said the expert.“But this will even help reduce the risks of serious complications, such as strokes, blindness and attacks.In the long term, an effective vaccine will represent a huge medical advance and transform the lives of patients with type 1 diabetes, ”he concluded.
In that sense, Professor Colin Dayan, from the Decardiff University, declared that "within four years" the first results of the studies will be seen for six potential treatments, "and in ten years we hope to see in the clinics the first therapies with therapies with therapies withvaccine for affected patients. ”